6-hydroxydopa has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, JY; Mai, LM; Pan, JT | 1 |
| Kostrzewa, RM | 1 |
| Alter, H; Domanskyi, A; Gass, P; Geissler, C; Parlato, R; Schober, A; Schütz, G; Vinnikov, IA; Vogt, MA | 1 |
1 review(s) available for 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Evolution of neurotoxins: from research modalities to clinical realities.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Benzylamines; Botulinum Toxins, Type A; Dihydroxyphenylalanine; Dihydroxytryptamines; Glutamic Acid; Humans; Models, Animal; Nerve Growth Factor; Neurosciences; Neurotoxins; Oxidopamine; Terminology as Topic | 2009 |
2 other study(ies) available for 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Neurons; Oxidopamine; Rats | 1993 |
Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopamine Agents; Gene Deletion; Gene Expression Regulation; Mice; Mice, Knockout; Neurons; Parkinson Disease; Pol1 Transcription Initiation Complex Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; TOR Serine-Threonine Kinases; Tyrosine 3-Monooxygenase | 2011 |